Document Type : Original Articles


1 Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran;

2 Infertility Research Center, School of Medicine, Gynecologist, Shiraz University of Medical Sciences, Shiraz, Iran;

3 Student Research Committee, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran;

4 Department of Community Health Nursing, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran


Background: Mastalgia is a common problem among women. Severe mastalgia can have a negative impact on sexual, physical and sleep activities and behaviors. Regarding the absence of a study on the prevalence and severity of mastalgia in southern Iran, the current study was conducted. Methods: This is an analytical cross-sectional study. The participants were women who referred to health centers affiliated to Shiraz University of Medical Sciences in Shiraz. The inclusion criteria were willingness to participate in the study, not being pregnant and breastfeed. The severity of breast pain was calculated with visual analog scale. The data of 845 questionnaires were analyzed with SPSS software. Results: The participants’ age ranged from 15-50 years; the mean age was 32.84±9.49 years. Among 845 participants, 33% (279) of them had experienced mastalgia in the past three months. Among those who had experienced mastalgia, 81% (226) had cyclical mastalgai and 19% (53) had non-cyclical mastalgia. The mean of pain score was 4.32±2.38 and 12.9% of the participants (36) had pain scores of 8 to 10. The impact of mastalgia on daily and sexual activities and sleep behaviors was reported 9.31% (26), 12.66% (29) and 13.97% (36), respectively. Conclusion: Results of this study showed that the spread of mastalgia in women referred to health centers affiliated to Shiraz University of Medical Sciences is lower than that reported in western studies and has lesser effects on their daily, sexual and sleep activities and behaviors. We suggest further studies about mastalgia in others locations in Iran.


  1. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and Management of Breast Pain. Mayo Clin Proc 2004; 79: 353-72.
  2. Millet AV, Dirbas FM. Clinical Management of Breast Pain: A Review. Obstet Gynecol Surv 2002; 57: 451-61.
  3. Parsay S, Olfati F, Nahidi S. Therapeutic Effects of Vitamin E on Cyclic Mastalgia. Breast J 2009; 15: 510-4.
  4. Santen RJ, Mansel R(). Benign breast disorders. N Engl J Med 2005; 353: 275-85.
  5. Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A. A systematic review of current understanding and management of mastalgia. Indian J Surg 2014; 76: 217-22.
  6. Barros AC, Mottola J, Ruiz CA, Borges MN, Pinotti JA. Reassurance in the Treatment of Mastalgia. Breast J 1999; 5: 162-5.
  7. Rosolowich V SE, Szuck B. Mastalgia. J Obstet Gynaecol Can 2006; 28: 49-74.
  8. Olawaiye A, Withiam-Leitch M, Danakas G, Kahn K. Mastalgia: a review of management. J Reprod Med 2005; 50: 933-9.
  9. Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 1997; 177: 126-32.
  10. Berek JS. Berek and Novak’s Gynecology. 15th ed. Philadelphia: Lippincott: Williams & Wilkins; p. 667-70, 2012.
  11. Fritz Ma SL. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Philadelphia: Lippincott: Williams & Wilkins, 2010.
  12. Goodwin PJ, Miller A, Del Giudice ME, Singer W, Connelly P, Ritchie JK. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol 1998; 179: 430-7.
  13. Sharami SH, Sobhani AR, Asgharnia M, Shabani M. Prevalence of cyclical mastalgia and its relation with age, marriage and employment outside the house. Journal Of Guilan University of Medical Sciences 2000; 9: 111-6.[in persian]
  14. Kaviani A, Majidzadeh K, Sadat Vahdaninia M. Breast pain frequency in Iranian women. Payash 2001; 1: 57-61. [in persian]
  15. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001; 8: 1153-7.
  16. Ader D, South-Paul J, Adera T, Deuster P. Cyclical mastalgia: prevalence and associated health and behavioral factors. Journal of Psychosomatic Obstetrics & Gynecology 2001; 22: 71-6.
  17. Leinster S, Whitehouse G, Walsh P. Cyclical mastalgia: clinical and mammographic observations in a screened population. Br J Surg 1987; 74: 220-2.
  18. Krishnaswamy U. Profile of benign breast diseases in urban India. Indian J Surg 2003; 65: 178- 81.
  19. Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999; 69: 492-4.
  20. Chowdhury RA. Analysis of Breast Pain: a Study of 110 Cases. J Med 2009; 10: 77-81.
  21. Carmichael AR, Bashayan O, Nightingale P. Objective analyses of mastalgia in breast clinics: is breast pain questionaire a useful tool in a busy breast clinic? Breast 2006; 15: 498-502.
  22. Scurr J, Hedger W, Morris P, Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J 2014; 20: 508-13.
  23. Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am 2013; 40: 459-73.
  24. Vaziri F, Zamani Lari M, Samsami Dehaghani A, Salehi M, Sadeghpour H, Akbarzadeh M. Comparing the effects of dietary flaxseed and omega-3 Fatty acids supplement on cyclical mastalgia in Iranian women: a randomized clinical trial. Int J Family Med 2014; 2014: 174532
  25. Maddox PR, Harrison BJ, Mansel RE, Hughes LE. Non-cyclical mastalgia: an improved classification and treatment. Br J Surg 1989; 76: 901-4.
  26. Morrow M. The Evaluation of Common Breast Problems. Am Fam Physician 2000; 61: 2371-8.